Navigation Links
Inovio Pharmaceuticals to Present at Investor Conferences
Date:4/29/2011

nobleresearch.com/a/research/conference.php

About Inovio Pharmaceuticals, Inc.

Inovio is developing a new generation of vaccines, called DNA vaccines, to treat and prevent cancers and infectious diseases. Its SynCon™ vaccines are designed to provide broad cross-strain protection against known as well as newly emergent strains of pathogens such as influenza. These vaccines, in combination with Inovio's proprietary electroporation delivery devices, have been shown to be safe and generate significant immune responses. Inovio's clinical programs include three separate programs in Phase II clinical studies, including VGX-3100 for treating cervical dysplasia and cancer. Other Inovio clinical programs include those for avian flu (preventive) and HIV vaccines (both preventive and therapeutic). Inovio is developing universal influenza and other vaccines in collaboration with scientists from the University of Pennsylvania. Other partners and collaborators include Merck, ChronTech, National Cancer Institute, U.S. Military HIV Research Program, NIH, HIV Vaccines Trial Network, University of Southampton, and PATH Malaria Vaccine Initiative. More information is available at www.inovio.com.

This press release contains certain forward-looking statements relating to our business, including our plans to develop electroporation-based drug and gene delivery technologies and DNA vaccines and our capital resources. Actual events or results may differ from the expectations set forth herein as a result of a number of factors, including uncertainties inherent in pre-clinical studies, clinical trials and product development programs (including, but not limited to, the fact that pre-clinical and clinical results referenced in this release may not be indicative of results achievable in other trials or for other indications, that the studies or trials may not be successful or achieve the results desired, that result
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Inovio Pharmaceuticals Closes $24.3 Million Registered Offering
2. University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
3. Inovio Pharmaceuticals Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial
4. Inovio Pharmaceuticals Unveils Needle-free, Contactless Electroporation Technology for DNA Vaccine Delivery
5. Inovio Pharmaceuticals to Present at Partnering and Scientific Conferences
6. Inovio Pharmaceuticals to Present at Cowen & Co. Health Care Conference
7. Inovio Pharmaceuticals to Present at ROTH 23rd Annual Growth Stock Conference
8. Inovio Pharmaceuticals Partner ChronTech Initiates Phase II Clinical Trial of Hepatitis C Virus DNA Vaccine Using Inovios Electroporation Delivery Technology
9. OncoSec Medical Licenses Non-DNA Vaccine Tumor Therapy Technology from Inovio Pharmaceuticals
10. Inovio Pharmaceuticals Licenses Non-DNA Vaccine Tumor Therapy Technology to OncoSec Medical
11. Inovio Pharmaceuticals Reports 2010 Fourth Quarter and Year End Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... 2015 BioClinica®, Inc ., ein ... gab heute bekannt, dass es mit MediciGroup ® ... und Erhalt von Patienten übernommen hat. Der ... Ltd. und Access to Patients, LLC. Medici bietet ... Auffinden von Patienten, die für die Nachbeobachtung verloren ...
(Date:7/7/2015)... 7, 2015 /PRNewswire/ -- Mindray Medical International Limited ("Mindray", ... and marketer of medical devices worldwide, announced today ... in Wuhan Dragonbio Surgical Implant Co., Ltd. ("Dragonbio") ... is a domestic medical orthopedic-product provider that specializes ... Prior to today,s announcement, Mindray already has a ...
(Date:7/7/2015)... 2015 Oasmia Pharmaceutical AB, a ... and veterinary oncology, has filed a registration statement on ... connection with the proposed public offering of ordinary stock ... of American Depositary Shares, representing ordinary shares, to be ... not yet been determined. An Investor Roadshow will be ...
Breaking Medicine Technology:BioClinica übernimmt MediciGroup 2BioClinica übernimmt MediciGroup 3BioClinica übernimmt MediciGroup 4Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 2Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 3Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 4Oasmia Pharmaceutical Files a Registration Statement on Form F-1/A for its Proposed Public Offering and an Application with NASDAQ for a US Listing and Announces Investor Roadshow 2
... COLORADO SPRINGS, Colo., Dec. 14, 2010 Cannabis Science, Inc. ... biotech company developing pharmaceutical cannabis products, is pleased to announce ... as its new base of operations in Denver, Colorado. The ... Unit H will be dedicated to housing executive offices, administrative ...
... 13, 2010 The board of directors of Pfizer Inc. ... 2011 dividend on the company,s common stock, payable March 1, ... on February 4, 2011.  Pfizer increased the dividend by approximately ... (Logo: http://photos.prnewswire.com/prnh/20100416/PFIZERLOGO) "This dividend increase is ...
Cached Medicine Technology:Cannabis Science Signs Lease for New 6,600 sq. ft. Corporate Headquarters and Laboratory Facility 2Cannabis Science Signs Lease for New 6,600 sq. ft. Corporate Headquarters and Laboratory Facility 3Pfizer Declares A 20-Cent First-Quarter 2011 Dividend 2
(Date:7/7/2015)... ... ... Today, the physicians at Allied Anesthesia, who provide services to Children’s Hospital of ... a series of tips to help children stay safe over the summer months. , ... unsupervised time outdoors. , The most common causes of injuries and death for ...
(Date:7/7/2015)... ... July 07, 2015 , ... The plastic ... mark on the cosmetic surgery industry with its commitment, teamwork, and dedication — ... partnered medical provider is committed to patient safety, world-class results, and compassionate care. ...
(Date:7/7/2015)... , ... July 07, 2015 ... ... convenience stores throughout the Southwest, including Giant, Mustang, Sun Dial and Howdy’s, ... program, surpassing their original 2015 fundraising goal by nearly $100,000, to help ...
(Date:7/7/2015)... ... 2015 , ... Ticket Down is a reputable source of authentic tickets for the 2015 CONCACAF ... Honduras at the Toyota Stadium. , The 2015 CONCACAF Gold Cup is now ... tournament, being held on American soil, will kick off in Frisco, CA from the Toyota ...
(Date:7/7/2015)... ... July 07, 2015 , ... Seattle-based ... have merged to form Camber Collective. Camber Collective provides strategic advisory services ... SwitchPoint’s strategy consulting expertise with Hope Consulting’s deep experience in customer insights, ...
Breaking Medicine News(10 mins):Health News:Allied Anesthesia Physicians Release Summertime Safety Tips 2Health News:Allied Anesthesia Physicians Release Summertime Safety Tips 3Health News:Top Plastic Surgery Provider in Brazil Joins VisitandCare.com 2Health News:Top Plastic Surgery Provider in Brazil Joins VisitandCare.com 3Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 2Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 3Health News:Panama vs Haiti & USA vs Honduras CONCACAF Group A Tickets at Toyota Stadium: Ticket Down Slashes Ticket Prices for Haiti vs Panama & USA vs Honduras in Frisco/Dallas 2Health News:Panama vs Haiti & USA vs Honduras CONCACAF Group A Tickets at Toyota Stadium: Ticket Down Slashes Ticket Prices for Haiti vs Panama & USA vs Honduras in Frisco/Dallas 3Health News:SwitchPoint and Hope Consulting Have Merged to Form Camber Collective 2
... catches on with yet another research study which says that eating ... in children. // , ,Researchers found that kids who ate ... have asthma attacks and wheezing. Other takeaway food and fizzy drinks ... ate at least one hamburger a week were 75 percent more ...
... the walls of a patient's room have been found ... and rheumatic complaints, a study says.//,A study group attached ... in medicated rooms were cured in shorter less time ... involved 36 patients, of whom 19 were kept in ...
... new medical device that is believed to allow bone ... quantities to permit far more research and allow faster ... difficulties in the growth and transplantation of stem cells. ... mimic conditions encountered by adult stem cells within the ...
... to tackle the issue of vaccination against Japanese Encephalitis ... country where the vaccine is available in a sizeable ... in Uttar Pradesh and Bihar has prompted the initiative ... also planned for detailed discussions with the Chinese minister ...
... Justice Silber is to give his verdict over the right ... consent or knowledge. The case which has been brought by ... pregnant. // ,The family planning association told the ... about contraception use and abortion does not match the views ...
... which could eventually lead to a practical and cost effective ... US National Cancer Institute have genetically modified bacteria living in ... // ,Most HIV transmission occurs on the surfaces ... with a layer of bacteria. ,The researchers have ...
Cached Medicine News:Health News:A warning for children consuming hamburgers: Asthma 2Health News:Now medicated coir to cure ailments 2Health News:Perfusion bioreactor could enhance stem cell research and application in the future 2Health News:Indian Government Keen On JE Vaccine Supply And Patenting Of Indian Medicine Formulations 2Health News:Genetically modified bacteria to combat HIV 2
Used with eye shield to cushion the eye. Eliminates need for taping shield. No sticky residue. Package 50 per box. Assorted colors....
Blue plastic shield for reduced glare. Packaged 12 per box....
Child size. Clear plastic. Accommodates either eye. Packaged 12 per box. Available in either adult or pediatric size....
Non-reflective black anodized aluminum. Selection of five pin hole sizes (0.8 mm to 1.5 mm). Overall length: 4.0 inches....
Medicine Products: